Prognostic Value of Serum β2-Microglobulin in Patients with Waldenström's Macroglobulinemia Requiring Treatment

Athanasios K. Anagnostopoulos; Konstantinos Zervas; Marie Christine Kyrtsonis; Argiris Symeonidis; Dimitra Gika; Konstantinos L. Bourantas; Athanasios Zomas; Nikolaos Anagnostopoulos; Gerasimos Pangalis; Meletios A Dimopoulos

doi:10.3816/clm.2006.n.060

Related publications

Article2005

Prognostic Value of Serum β2-Microglobulin in Patients with Waldenstrom’s Macroglobulinemia Requiring Treatment.

Athanasios K. Anagnostopoulos, Konstantinos Zervas, Evangelos Terpos, Marie Christine Kyrtsonis, Argiris Symeonidis, Dimitra Gika, Konstantinos L. Bourantas, Athanasios Zomas, Nikolaos Angnostopoulos, Gerasimos Pangalis, Meletios A Dimopoulos

Article2004

Treatment of Waldenstrom's Macroglobulinemia with Rituximab: Prognostic Factors for Response and Progression

Meletios A Dimopoulos, Raymond Alexanian, Dimitra Gika, Athanasios K. Anagnostopoulos, Constantinos Zervas, Athanassios Zomas, Marie Christine Kyrtsonis, Nicolaos Anagnostopoulos, Gerassimos A. Pangalis, Donna M. Weber

Article2003

Survival and prognostic factors after initiation of treatment in Waldenstrom’s macroglobulinemia

Meletios A Dimopoulos, George Hamilos, Konstantinos Zervas, Argiris Symeonidis, G. Kouvatseas, Paraskevi Roussou, Dimitra Gika, Efthymios Karmiris, Konstantinos L. Bourantas, Athanasios Zomas, C. Mitsouli, Irini Xilouri, E. Vervessou, K. Matsis, Nicolaos Anagnostopoulos, T. Economopoulos

Article2010

Bortezomib as a Treatment Option in Patients With Waldenström Macroglobulinemia

Meletios A Dimopoulos, Christine Chen, Efstathios Kastritis, Maria Gavriatopoulou, Steven P. Treon

Article2002

Treatment of Waldenström’s Macroglobulinemia With Rituximab

Meletios A Dimopoulos, Constantinos Zervas, Athanassios Zomas, Christos Kiamouris, Nora Viniou, Vassiliki Grigoraki, Christos Karkantaris, Chrisanthi Mitsouli, Dimitra Gika, John Christakis, Nikolaos Anagnostopoulos